Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Divestments (2012 - 2025)

Grifols' (GIFLF) quarterly Divestments came in at -$125.7 million in Q4 2025, up 58.86% on a YoY basis from -$79.1 million in Q4 2024, and up 58.86% quarter-over-quarter from -$305.6 million in Q4 2024.

Analysis

Grifols (GIFLF) Divestments (2012 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Divestments for 8 consecutive years, with -$125.7 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Divestments rose 58.86% year-over-year to -$125.7 million; the trailing twelve-month figure through Dec 2025 stood at -$2.0 billion (down 3.06% YoY), and the FY2025 full-year result was -$122.0 million, up 60.07% from the prior year.
  • Divestments climbed to -$125.7 million in Q4 2025 per GIFLF's latest filing, from -$305.6 million in the prior quarter.
  • Across five years, Divestments topped out at -$31.2 million in Q4 2023 and bottomed at -$1.6 billion in Q4 2022.
  • Historically, Divestments has averaged -$506.7 million across 4 years, with a median of -$215.7 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Divestments surged 98.01% in 2023, then sank 879.47% in 2024.
  • Over 4 years, Divestments stood at -$1.6 billion in 2022, then soared by 98.01% to -$31.2 million in 2023, then plunged by 879.47% to -$305.6 million in 2024, then surged by 58.86% to -$125.7 million in 2025.
  • According to Business Quant data, Divestments over the past three periods registered -$125.7 million, -$305.6 million, and -$31.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn -
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn -
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn -
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn -
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn -
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn -
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn -125.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -125.72 Mn
Dec 31, 2024 -305.62 Mn
Dec 31, 2023 -31.20 Mn
Dec 31, 2022 -1.56 Bn
Mar 31, 2015 -65.58 Mn
Mar 31, 2014 1.66 Bn
Dec 31, 2013 -18.48 Mn
Sep 30, 2013 -25.84 Mn
Dec 31, 2012 2.50 Mn
Sep 30, 2012 1.88 Mn